Kanada - engleski - Health Canada

jamp pharma corporation - efavirenz - tablet - 600mg - efavirenz 600mg - nonnucleoside reverse transcriptase inhibitors

Velika Britanija - engleski - myHealthbox

milpharm limited - efavirenz. - film-coated tablets - 600mg - non-nucleoside reverse transcriptase inhibitors - it is indicated in antiviral combination treatment of human immunodeficiency virus-1 (hiv-1) infected adults, adolescents and children 3 years of age and older.

Australija - engleski - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - efavirenz, quantity: 600 mg - tablet, film coated - excipient ingredients: magnesium stearate; microcrystalline cellulose; croscarmellose sodium; hyprolose; lactose monohydrate; colloidal anhydrous silica; titanium dioxide; hypromellose; iron oxide yellow; iron oxide red; macrogol 400 - efavirenz alphapharm is indicated for use in combination with other antiviral agents for the treatment of hiv-1 infection in adults and children

Australija - engleski - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - efavirenz, quantity: 600 mg - tablet, film coated - excipient ingredients: microcrystalline cellulose; lactose monohydrate; magnesium stearate; hyprolose; croscarmellose sodium; colloidal anhydrous silica; titanium dioxide; hypromellose; iron oxide yellow; iron oxide red; macrogol 400 - efavirenz alphapharm is indicated for use in combination with other antiviral agents for the treatment of hiv-1 infection in adults and children.

Velika Britanija - engleski - MHRA (Medicines & Healthcare Products Regulatory Agency)

mylan - efavirenz - tablet - 600mg

Velika Britanija - engleski - MHRA (Medicines & Healthcare Products Regulatory Agency)

milpharm ltd - efavirenz - tablet - 600mg

Malta - engleski - Medicines Authority

1 a pharma gmbh - efavirenz 600 mg - film-coated tablet

Velika Britanija - engleski - MHRA (Medicines & Healthcare Products Regulatory Agency)

dr reddy's laboratories (uk - efavirenz; tenofovir disoproxil fumarate; emtricitabine - tablet - 600mg ; 245mg ; 200mg

Sjedinjene Američke Države - engleski - NLM (National Library of Medicine)

remedyrepack inc. - efavirenz (unii: je6h2o27p8) (efavirenz - unii:je6h2o27p8) - efavirenz 600 mg - sustiva ® (efavirenz) in combination with other antiretroviral agents is indicated for the treatment of human immunodeficiency virus type 1 (hiv-1) infection in adults and in pediatric patients at least 3 months old and weighing at least 3.5 kg. - sustiva is contraindicated in patients with previously demonstrated clinically significant hypersensitivity (eg, stevens-johnson syndrome, erythema multiforme, or toxic skin eruptions) to any of the components of this product. - coadministration of efavirenz with elbasvir and grazoprevir is contraindicated [see warnings and precautions ( 5.1) and drug interactions ( 7.1) ]. pregnancy exposure registry there is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to sustiva during pregnancy. physicians are encouraged to register patients by calling the antiretroviral pregnancy registry at 1-800-258-4263. there are retrospective case reports of neural tube defects in infants whose mothers were exposed to efavirenz-containing regimens in th

Sjedinjene Američke Države - engleski - NLM (National Library of Medicine)

bristol-myers squibb pharma company - efavirenz (unii: je6h2o27p8) (efavirenz - unii:je6h2o27p8) - efavirenz 50 mg - sustiva® (efavirenz) in combination with other antiretroviral agents is indicated for the treatment of human immunodeficiency virus type 1 (hiv-1) infection in adults and in pediatric patients at least 3 months old and weighing at least 3.5 kg. - sustiva is contraindicated in patients with previously demonstrated clinically significant hypersensitivity (eg, stevens-johnson syndrome, erythema multiforme, or toxic skin eruptions) to any of the components of this product. - coadministration of efavirenz with elbasvir and grazoprevir is contraindicated [see warnings and precautions (5.1) and drug interactions (7.1) ]. pregnancy exposure registry there is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to sustiva during pregnancy. physicians are encouraged to register patients by calling the antiretroviral pregnancy registry at 1-800-258-4263. there are retrospective case reports of neural tube defects in infants whose mothers were exposed to efavirenz-containing regimens in the fi